Phase I clinical trial of safety of L-serine for ALS patients.
Levine TD, Miller RG, Bradley WG, Moore DH, Saperstein DS, Flynn LE, Katz JS, Forshew DA, Metcalf JS, Banack SA, Cox PA.
Levine TD, et al. Among authors: metcalf js.
Amyotroph Lateral Scler Frontotemporal Degener. 2017 Feb;18(1-2):107-111. doi: 10.1080/21678421.2016.1221971. Epub 2016 Sep 2.
Amyotroph Lateral Scler Frontotemporal Degener. 2017.
PMID: 27589995
Clinical Trial.